DK63488A - Anvendelse af human blod-koagulationsfaktor xiii til behandling af ulcerativ colitis - Google Patents

Anvendelse af human blod-koagulationsfaktor xiii til behandling af ulcerativ colitis

Info

Publication number
DK63488A
DK63488A DK063488A DK63488A DK63488A DK 63488 A DK63488 A DK 63488A DK 063488 A DK063488 A DK 063488A DK 63488 A DK63488 A DK 63488A DK 63488 A DK63488 A DK 63488A
Authority
DK
Denmark
Prior art keywords
treatment
factor xiii
blood coagulation
human blood
coagulation factor
Prior art date
Application number
DK063488A
Other languages
Danish (da)
English (en)
Other versions
DK63488D0 (da
Inventor
Mikio Urabe
Satoshi Tanaka
Kenichiro Tsumura
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12192122&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK63488(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of DK63488D0 publication Critical patent/DK63488D0/da
Publication of DK63488A publication Critical patent/DK63488A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
DK063488A 1987-02-09 1988-02-08 Anvendelse af human blod-koagulationsfaktor xiii til behandling af ulcerativ colitis DK63488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62026387A JPS63196520A (ja) 1987-02-09 1987-02-09 潰瘍性大腸炎治療剤

Publications (2)

Publication Number Publication Date
DK63488D0 DK63488D0 (da) 1988-02-08
DK63488A true DK63488A (da) 1988-08-10

Family

ID=12192122

Family Applications (1)

Application Number Title Priority Date Filing Date
DK063488A DK63488A (da) 1987-02-09 1988-02-08 Anvendelse af human blod-koagulationsfaktor xiii til behandling af ulcerativ colitis

Country Status (16)

Country Link
US (1) US5378687A (de)
EP (1) EP0278416B1 (de)
JP (1) JPS63196520A (de)
KR (1) KR960014789B1 (de)
AT (1) ATE83665T1 (de)
AU (1) AU615428B2 (de)
CA (1) CA1322161C (de)
DE (1) DE3876817T2 (de)
DK (1) DK63488A (de)
ES (1) ES2052614T3 (de)
GR (1) GR3007331T3 (de)
HU (1) HU200277B (de)
IE (1) IE61713B1 (de)
IL (1) IL85346A (de)
PT (1) PT86721B (de)
ZA (1) ZA88852B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤
AU3428493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Novel human transglutaminases
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
JP2005507926A (ja) 2001-10-09 2005-03-24 ザイモジェネティクス，インコーポレイティド 第ＸＩＩＩ因子を用いてセロマ（ｓｅｒｏｍａ）の形成を阻害するための方法
JP2006501242A (ja) * 2002-08-23 2006-01-12 ザイモジェネティクス， インク． 炎症性腸疾患の治療方法
CA2587139C (en) 2004-11-23 2014-05-27 Zymogenetics, Inc. Purification of recombinant human factor xiii
US20140286927A1 (en) * 2012-06-19 2014-09-25 Peter Edward Smith Method for the treatment of ulcerative colitis in patients refractory to steroid therapy using leached ligand fibrin stabilizing composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法

Also Published As

Publication number Publication date
PT86721B (pt) 1992-05-29
DE3876817D1 (de) 1993-02-04
IL85346A0 (en) 1988-07-31
ES2052614T3 (es) 1994-07-16
GR3007331T3 (de) 1993-07-30
HUT47221A (en) 1989-02-28
JPS63196520A (ja) 1988-08-15
ZA88852B (en) 1988-11-30
IL85346A (en) 1992-07-15
KR880009661A (ko) 1988-10-04
DK63488D0 (da) 1988-02-08
AU1138288A (en) 1988-08-11
CA1322161C (en) 1993-09-14
US5378687A (en) 1995-01-03
HU200277B (en) 1990-05-28
EP0278416A3 (en) 1990-07-11
AU615428B2 (en) 1991-10-03
ATE83665T1 (de) 1993-01-15
PT86721A (pt) 1988-03-01
DE3876817T2 (de) 1993-05-19
JPH0437049B2 (de) 1992-06-18
EP0278416B1 (de) 1992-12-23
IE61713B1 (en) 1994-11-30
KR960014789B1 (en) 1996-10-19
EP0278416A2 (de) 1988-08-17
IE880334L (en) 1988-08-09

Similar Documents

Publication Publication Date Title
DK148889D0 (da) Fremgangsmaade til foroegelse af extracellulaert adenosin og til stabilisering af mastceller
DK554589A (da) Injektionsapparat med spaendeorgan
DE69121704D1 (de) Kombinationskatheter zur beobachtung und zur dilatation von blutgefässen
NO885109D0 (no) FremgangsmŸte og middel for Ÿ forhindre blodpropp.
DK549189D0 (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
DK411889D0 (da) Optisk sensor til maaling af oxygen-maetningsgraden i haemoglobin og haemoglobinkoncentrationen i blod eller i en organisme
DK63488D0 (da) Anvendelse af human blod-koagulationsfaktor xiii til behandling af ulcerativ colitis
DE3855527D1 (de) Doppelsträngige RNS zur Korrektur von Abnormalitäten von zirkulierenden Immunkomplexen und der Monozytenfunktion
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
ATE7107T1 (de) Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln.
FI864570A0 (fi) Terapeutiskt anvaendbar foerening.
ATE81455T1 (de) (s)-emopamil zur anwendung bei der behandlung von migraene.
DE3764697D1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
DE3750248D1 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
ATE107166T1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
FR2618672B1 (fr) Utilisation dans le traitement de l'acne et de la seborrhee d'une composition contenant un hydroperoxyde
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
DE3572033D1 (en) Method for diagnosis of a.i.d.s.
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
NO901735L (no) Anordning og fremgangsmaate for fjerning av leukocytt-innholdet i blod og blodkomponenter.
BR6601685U (pt) Disposicao introduzida em suporte de mascaras de oxigenio ou outros
IT1218512B (it) Apparecchio monouso schermante del viso nelle pratiche medicali

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment